Pavmed Inc Stock Performance
| PAVM Stock | USD 10.80 0.22 2.08% |
On a scale of 0 to 100, PAVmed holds a performance score of 4. The firm holds a Beta of 4.43, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PAVmed will likely underperform. Please check PAVmed's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether PAVmed's historical price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, PAVmed displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.08 | Five Day Return 30.43 | Year To Date Return 47.34 | Ten Year Return (99.52) | All Time Return (99.52) |
Last Split Factor 1:30 | Last Split Date 2026-01-02 |
1 | Will PAVmed Inc. stock benefit from upcoming earnings reports - Portfolio Risk Summary Technical Pattern Alert System - newser.com | 11/19/2025 |
2 | Hyperfine and Lucid Diagnostics Financial Review | 11/26/2025 |
3 | Lucid Diagnostics reports 95 percent EsoCheck success in 11,991 patients - Stock Titan | 12/09/2025 |
4 | Nasdaq Moves Will PAVmed Inc. stock gain from strong economy - Earnings Trend Report Reliable Price Breakout Alerts - ulpravda.ru | 12/19/2025 |
5 | PAVmed announces 1-for-30 reverse stock split | 12/30/2025 |
6 | PAVmed Inc. Short Interest Up 164.6 percent in December | 01/14/2026 |
7 | Individual investors among Lucid Diagnostics Inc.s largest stockholders and were hit after last weeks 14 percent price drop | 01/23/2026 |
8 | Acquisition by Aklog Lishan of 150000 shares of PAVmed subject to Rule 16b-3 | 02/03/2026 |
9 | PAVmed Restructures Capital With New Preferred Financing - TipRanks | 02/04/2026 |
| Begin Period Cash Flow | 19.6 M | |
| Total Cashflows From Investing Activities | -16.2 M |
PAVmed Relative Risk vs. Return Landscape
If you would invest 1,004 in PAVmed Inc on November 10, 2025 and sell it today you would earn a total of 76.00 from holding PAVmed Inc or generate 7.57% return on investment over 90 days. PAVmed Inc is currently generating 0.8845% in daily expected returns and assumes 14.4417% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than PAVmed, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PAVmed Target Price Odds to finish over Current Price
The tendency of PAVmed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.80 | 90 days | 10.80 | about 17.4 |
Based on a normal probability distribution, the odds of PAVmed to move above the current price in 90 days from now is about 17.4 (This PAVmed Inc probability density function shows the probability of PAVmed Stock to fall within a particular range of prices over 90 days) .
PAVmed Price Density |
| Price |
Predictive Modules for PAVmed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PAVmed Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PAVmed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PAVmed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PAVmed is not an exception. The market had few large corrections towards the PAVmed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PAVmed Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PAVmed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 4.43 | |
σ | Overall volatility | 1.46 | |
Ir | Information ratio | 0.03 |
PAVmed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PAVmed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PAVmed Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PAVmed Inc is way too risky over 90 days horizon | |
| PAVmed Inc appears to be risky and price may revert if volatility continues | |
| PAVmed Inc has high likelihood to experience some financial distress in the next 2 years | |
| PAVmed Inc currently holds about 68.47 M in cash with (33.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: PAVmed Restructures Capital With New Preferred Financing - TipRanks |
PAVmed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PAVmed Stock often depends not only on the future outlook of the current and potential PAVmed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PAVmed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.2 M | |
| Cash And Short Term Investments | 1.2 M |
PAVmed Fundamentals Growth
PAVmed Stock prices reflect investors' perceptions of the future prospects and financial health of PAVmed, and PAVmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PAVmed Stock performance.
| Return On Equity | 0.17 | ||||
| Return On Asset | -0.37 | ||||
| Profit Margin | 106.72 % | ||||
| Operating Margin | (968.80) % | ||||
| Current Valuation | 43.66 M | ||||
| Shares Outstanding | 921.28 K | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 343.10 X | ||||
| Revenue | 3 M | ||||
| Gross Profit | (152 K) | ||||
| EBITDA | 29.67 M | ||||
| Net Income | 28.43 M | ||||
| Cash And Equivalents | 68.47 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 31.86 M | ||||
| Debt To Equity | 0.79 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 11.00 X | ||||
| Cash Flow From Operations | (33.55 M) | ||||
| Earnings Per Share | (12.00) X | ||||
| Market Capitalization | 9.95 M | ||||
| Total Asset | 30.66 M | ||||
| Retained Earnings | (254.97 M) | ||||
| Working Capital | (33.28 M) | ||||
| Current Asset | 1.97 M | ||||
| Current Liabilities | 842 K | ||||
About PAVmed Performance
By examining PAVmed's fundamental ratios, stakeholders can obtain critical insights into PAVmed's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that PAVmed is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 18.49 | 17.57 | |
| Return On Tangible Assets | 1.17 | 1.23 | |
| Return On Capital Employed | 8.37 | 6.16 | |
| Return On Assets | 1.17 | 1.23 | |
| Return On Equity | (18.34) | (17.42) |
Things to note about PAVmed Inc performance evaluation
Checking the ongoing alerts about PAVmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PAVmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PAVmed Inc is way too risky over 90 days horizon | |
| PAVmed Inc appears to be risky and price may revert if volatility continues | |
| PAVmed Inc has high likelihood to experience some financial distress in the next 2 years | |
| PAVmed Inc currently holds about 68.47 M in cash with (33.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: PAVmed Restructures Capital With New Preferred Financing - TipRanks |
- Analyzing PAVmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PAVmed's stock is overvalued or undervalued compared to its peers.
- Examining PAVmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PAVmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PAVmed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PAVmed's stock. These opinions can provide insight into PAVmed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.